Plain-English translation of NCT06355258 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This research study is testing whether a medication called can prevent blood clots—a serious complication that sometimes happens in COVID-19 patients. Researchers want to see if this treatment is effective and safe when given to people with mild or severe COVID-19. About 80 participants will receive either the medication or a placebo (a dummy pill with no active drug) to compare how well it works.
COVID-19 can cause abnormal blood clotting in some patients, which can lead to serious complications like strokes or pulmonary embolism. Doctors hope this medication might help prevent these dangerous clots and improve outcomes for COVID-19 patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will take either the medication or a placebo pill once daily for 7 days. You will visit the clinic on days 1, 4, 7, and 28 for checkups and blood tests to see how you're doing. You'll also keep a diary to track any symptoms, bleeding, or clotting events during the study.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China
Phase
Safety & dosing
Sponsor
Westlake University
Collaborators
Shaoxing Central Hospital, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Enrollment target
~80 participants
Started
December 2023
Primary completion
December 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Xu Li, PhD
Westlake University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.